C-reactive protein as a marker of persistent Chlamydia trachomatis infection is not associated with tubal factor infertility-an independent clinical validation study.

Autor: Jansen M; Institute for Public Health Genomics, Department of Genetics and Cell Biology, School for Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, 6229 ER, Maastricht, The Netherlands.; Amsterdam UMC, Location VUmc, Department of Medical Microbiology and Infection Control, Laboratory of Immunogenetics,1081 HZ, Amsterdam, The Netherlands.; Amsterdam UMC, Location VUmc, Department of Clinical Genetics, Section Community Genetics, Amsterdam Public Health Research Institute, 1081 HV, Amsterdam, The Netherlands., van Ess E; Amsterdam UMC, Location VUmc, Department of Medical Microbiology and Infection Control, Laboratory of Immunogenetics,1081 HZ, Amsterdam, The Netherlands., Ouburg S; Amsterdam UMC, Location VUmc, Department of Medical Microbiology and Infection Control, Laboratory of Immunogenetics,1081 HZ, Amsterdam, The Netherlands., Gerds M; Department of Emergency Medicine, Hospital Tjongerschans, 8441 PW Heerenveen, The Netherlands., Morré S; Institute for Public Health Genomics, Department of Genetics and Cell Biology, School for Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, 6229 ER, Maastricht, The Netherlands.; Amsterdam UMC, Location VUmc, Department of Medical Microbiology and Infection Control, Laboratory of Immunogenetics,1081 HZ, Amsterdam, The Netherlands., Land J; Institute for Public Health Genomics, Department of Genetics and Cell Biology, School for Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, 6229 ER, Maastricht, The Netherlands.

Publikováno v: Human reproduction open [Hum Reprod Open] 2019 Dec 16; Vol. 2019 (4), pp. hoz029. Date of Electronic Publication: 2019 Dec 16 (Print Publication: 2019).

Comparison of the Mikrogen multi-target ELISA with the Mikrogen recomLine immunoblot for the detection of Chlamydia trachomatis IgG antibodies in serum in infertile women.

Autor: van Ess EF; VU University Medical Center, Department of Medical Microbiology & Infection Control, Laboratory of Immunogenetics, Amsterdam, The Netherlands. Electronic address: e.vaness@vumc.nl., Ouburg S; VU University Medical Center, Department of Medical Microbiology & Infection Control, Laboratory of Immunogenetics, Amsterdam, The Netherlands., Land JA; Institute for Public Health Genomics (IPHG), Department of Genetics and Cell Biology, Research Institute GROW, Faculty of Health, Medicine & Life Sciences, University of Maastricht, Maastricht, The Netherlands., Morré SA; VU University Medical Center, Department of Medical Microbiology & Infection Control, Laboratory of Immunogenetics, Amsterdam, The Netherlands; Institute for Public Health Genomics (IPHG), Department of Genetics and Cell Biology, Research Institute GROW, Faculty of Health, Medicine & Life Sciences, University of Maastricht, Maastricht, The Netherlands.

Publikováno v: Journal of microbiological methods [J Microbiol Methods] 2018 Jul; Vol. 150, pp. 5-8. Date of Electronic Publication: 2018 May 07.

Chlamydia trachomatis Strain Types Have Diversified Regionally and Globally with Evidence for Recombination across Geographic Divides.

Autor: Smelov V; International Agency for Research on Cancer, World Health Organization, Lyon, France.; Karolinska Institute, Stockholm, Sweden.; North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia., Vrbanac A; UCSF Benioff Children's Hospital Oakland Research Institute, Oakland, CA, United States., van Ess EF; Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, Netherlands., Noz MP; Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, Netherlands., Wan R; UCSF Benioff Children's Hospital Oakland Research Institute, Oakland, CA, United States., Eklund C; Karolinska Institute, Stockholm, Sweden., Morgan T; UCSF Benioff Children's Hospital Oakland Research Institute, Oakland, CA, United States., Shrier LA; Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States., Sanders B; UCSF Benioff Children's Hospital Oakland Research Institute, Oakland, CA, United States., Dillner J; Karolinska Institute, Stockholm, Sweden., de Vries HJC; Center for Infection and Immunology Amsterdam, Academic Medical Center, Amsterdam, Netherlands.; Department of Dermatology, Academic Medical Center, Amsterdam, Netherlands.; STI Outpatient Clinic, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, Netherlands., Morre SA; Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, Netherlands.; Institute of Public Health Genomics, Department of Genetics and Cell Biology, Research Institute GROW (School for Oncology and Developmental Biology), Faculty of Health, Medicine and Life Sciences, University of Maastricht, Maastricht, Netherlands., Dean D; UCSF Benioff Children's Hospital Oakland Research Institute, Oakland, CA, United States.; Department of Bioengineering, University of California, Berkeley, Berkeley, CA, United States.; Department of Bioengineering, University of California, San Francisco, San Francisco, CA, United States.; Departments of Medicine and Pediatrics, University of California, San Francisco, San Francisco, CA, United States.

Publikováno v: Frontiers in microbiology [Front Microbiol] 2017 Nov 13; Vol. 8, pp. 2195. Date of Electronic Publication: 2017 Nov 13 (Print Publication: 2017).

NOD1 in contrast to NOD2 functional polymorphism influence Chlamydia trachomatis infection and the risk of tubal factor infertility.

Autor: Branković I; Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, 1081 HV Amsterdam, The Netherlands Institute for Public Health Genomics, Department of Genetics and Cell Biology, School for Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200 MD Maastricht, The Netherlands., van Ess EF; Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, 1081 HV Amsterdam, The Netherlands., Noz MP; Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, 1081 HV Amsterdam, The Netherlands., Wiericx WA; Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, 1081 HV Amsterdam, The Netherlands., Spaargaren J; Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, 1081 HV Amsterdam, The Netherlands., Morré SA; Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, 1081 HV Amsterdam, The Netherlands Institute for Public Health Genomics, Department of Genetics and Cell Biology, School for Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200 MD Maastricht, The Netherlands Dutch Chlamydia trachomatis Reference Laboratory, Department of Medical Microbiology and Infection Control, VU University Medical Center, 1081 HV Amsterdam, The Netherlands samorretravel@yahoo.co.uk., Ouburg S; Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, 1081 HV Amsterdam, The Netherlands.

Publikováno v: Pathogens and disease [Pathog Dis] 2015 Feb; Vol. 73 (1), pp. 1-9. Date of Electronic Publication: 2015 Jan 11.